Page last updated: 2024-10-24

antigen processing and presentation of endogenous peptide antigen via MHC class I

Definition

Target type: biologicalprocess

The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex. The peptide antigen is typically, but not always, processed from a whole protein. Class I here refers to classical class I molecules. [GOC:add, ISBN:0781735149, PMID:15771591]

Endogenous antigen processing and presentation via MHC class I is a complex process that allows cells to display fragments of intracellular proteins, known as peptides, on their surface for recognition by cytotoxic T lymphocytes (CTLs). This process is essential for the immune system to detect and eliminate cells infected with viruses, bacteria, or other pathogens, as well as tumor cells.

The process begins with the degradation of intracellular proteins within the cytoplasm. This degradation can occur through various pathways, including the proteasome, a large protein complex that breaks down proteins into short peptides. The proteasome is highly regulated and can be influenced by factors like interferon-gamma (IFN-γ), a cytokine that enhances its activity.

The generated peptides are then transported into the endoplasmic reticulum (ER), a network of membranes within the cell. This transport is mediated by the transporter associated with antigen processing (TAP) complex, a heterodimer that recognizes and translocates peptides across the ER membrane. The TAP complex exhibits a preference for peptides with a specific length and amino acid sequence, ensuring that only relevant peptides are transported.

Within the ER, peptides encounter major histocompatibility complex (MHC) class I molecules. MHC class I molecules are cell surface receptors that present peptides to CTLs. They are composed of a heavy chain and a light chain called β2-microglobulin. The heavy chain consists of three domains: α1, α2, and α3. The α1 and α2 domains form a peptide-binding groove where peptides are loaded.

The peptide loading process is facilitated by chaperone proteins, such as tapasin, calreticulin, and ERp57. These proteins help to stabilize the MHC class I molecule and ensure proper peptide binding. The peptide must be the right size and sequence to fit into the groove and form a stable complex.

Once loaded with a peptide, the MHC class I molecule is transported to the cell surface via the Golgi apparatus. At the cell surface, the MHC class I-peptide complex is displayed for recognition by CTLs.

CTLs express T cell receptors (TCRs) that recognize specific MHC class I-peptide complexes. When a TCR encounters its cognate antigen, it triggers a signaling cascade that leads to the activation of the CTL. Activated CTLs can then kill the target cell through the release of cytotoxic granules containing perforin and granzyme.

In summary, the process of endogenous antigen processing and presentation via MHC class I involves the degradation of intracellular proteins, peptide transport into the ER, peptide loading onto MHC class I molecules, and display of the MHC class I-peptide complex on the cell surface for recognition by CTLs. This process is essential for the immune system to detect and eliminate cells infected with pathogens or harboring abnormal proteins.'
"

Proteins (4)

ProteinDefinitionTaxonomy
Endoplasmic reticulum aminopeptidase 1An endoplasmic reticulum aminopeptidase 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9NZ08]Homo sapiens (human)
Endoplasmic reticulum aminopeptidase 2An endoplasmic reticulum aminopeptidase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q6P179]Homo sapiens (human)
Insulin-degrading enzymeAn insulin-degrading enzyme that is encoded in the genome of human. [PRO:DNx, UniProtKB:P14735]Homo sapiens (human)
HLA class I histocompatibility antigen, A alpha chain An MHC class I histocompatibility antigen A alpha chain that is encoded in the genome of human. [PRO:DAN]Homo sapiens (human)

Compounds (17)

CompoundDefinitionClassesRoles
astemizoleastemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.

Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
benzimidazoles;
piperidines
anti-allergic agent;
anticoronaviral agent;
H1-receptor antagonist
ebselenebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.benzoselenazoleanti-inflammatory drug;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 3.5.4.1 (cytosine deaminase) inhibitor;
EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor;
enzyme mimic;
ferroptosis inhibitor;
genotoxin;
hepatoprotective agent;
neuroprotective agent;
radical scavenger
haloperidolhaloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
aromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol
antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
rabeprazoleRabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.benzimidazoles;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
spiperonespiperone : An azaspiro compound that is 1,3,8-triazaspiro[4.5]decane which is substituted at positions 1, 4, and 8 by phenyl, oxo, and 4-(p-fluorophenyl)-4-oxobutyl groups, respectively.

Spiperone: A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
aromatic ketone;
azaspiro compound;
organofluorine compound;
piperidines;
tertiary amino compound
alpha-adrenergic antagonist;
antipsychotic agent;
dopaminergic antagonist;
psychotropic drug;
serotonergic antagonist
cefmetazolecefmetazole : A second-generation cephalosporin antibiotic having N(1)-methyltetrazol-5-ylthiomethyl, {[(cyanomethyl)sulfanyl]acetyl}amino and methoxy side-groups at positions 3, 7beta and 7alpha respectively of the parent cephem bicyclic structure.

Cefmetazole: A semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms. It has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.
cephalosporinantibacterial drug
raloxifene hydrochlorideraloxifene hydrochloride : A hydrochloride salt resulting from the reaction of equimolar amounts of raloxifene and hydrogen chloride.

Raloxifene Hydrochloride: A second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.
hydrochloridebone density conservation agent;
estrogen antagonist;
estrogen receptor modulator
trazodone hydrochloridetrazodone hydrochloride : A hydrochloride salt prepared from equimolar amounts of trazodone and hydrogen chloride.

Triticum: A plant genus of the family POACEAE that is the source of EDIBLE GRAIN. A hybrid with rye (SECALE CEREALE) is called TRITICALE. The seed is ground into FLOUR and used to make BREAD, and is the source of WHEAT GERM AGGLUTININS.
hydrochlorideadrenergic antagonist;
antidepressant;
H1-receptor antagonist;
sedative;
serotonin uptake inhibitor
doxazosin mesylateCardura: Trade name in United States.methanesulfonate saltgeroprotector
ubenimexubenimex: growth inhibitor
angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-angiotensin II, des-Asp(1)-des-Arg(2)-Ile(5)-: 3-8 hexapeptide fragment of angiotensin II; smallest potent angiotensin II antagonistorganic molecular entity
vatalanibmonochlorobenzenes;
phthalazines;
pyridines;
secondary amino compound
angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
vascular endothelial growth factor receptor antagonist
leucine phosphonic acidleucine phosphonic acid: a leucine aminopeptidase antagonist; structure given in first source
myricetin7-hydroxyflavonol;
hexahydroxyflavone
antineoplastic agent;
antioxidant;
cyclooxygenase 1 inhibitor;
food component;
geroprotector;
hypoglycemic agent;
plant metabolite
mart-1 antigenMART-1 Antigen: A melanosome-specific protein that plays a role in the expression, stability, trafficking, and processing of GP100 MELANOMA ANTIGEN, which is critical to the formation of Stage II MELANOSOMES. The protein is used as an antigen marker for MELANOMA cells.
1-amino-3-phenylpropylphosphonic acid1-amino-3-phenylpropylphosphonic acid: inhibits L-phenylalanine ammonia-lyase activity of higher plants
rolitetracyclinerolitetracycline : A derivative of tetracycline in which the amide function is substituted with a pyrrolidinomethyl group.

Rolitetracycline: A pyrrolidinylmethyl TETRACYCLINE.